Guardant Health, Inc. (NASDAQ:GH) Q4 2025 Earnings Call Transcript
Operator: Thank you for attending the Guardant Health Q4 2025 Earnings Call. My name is Cameron, and I'll be your moderator for today.
Guardant Health Inc. (GH)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 2,800,000 | $285,992,000 | -33% | 5.1% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 2,382,300 | $243,328,122 | +13% | 0.47% |
| 3. | Driehaus Capital Richard Driehaus | 2,143,193 | $218,905,733 | -1% | 1.49% |
| 4. | 104,854,000 | $192,312,721 | -53% | 6.15% | |
| 5. | Point72 Asset Management Steve Cohen | 1,499,169 | $153,125,122 | +1364% | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.82 | 2,187 | $38,962.72 | 12,722 | 2024-03-18 | Filing | |
| $32.78 | 750 | $24,584.25 | 5,193 | 2023-06-09 | Filing | |
| $32.68 | 2,231 | $72,913.77 | 4,443 | 2023-06-09 | Filing | |
| $26.15 | 8,600 | $224,927.84 | 2,049,238 | 2023-03-15 | Filing | |
| $26.33 | 84,452 | $2,223,908.30 | 2,040,638 | 2023-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $115.70 | 3,249 | $375,902.15 | 20,990 | 2026-01-21 | Filing | |
| $113.48 | 3,619 | $410,681.59 | 24,239 | 2026-01-21 | Filing | |
| $112.34 | 1,703 | $191,318.09 | 27,858 | 2026-01-21 | Filing | |
| $113.44 | 88 | $9,982.69 | 20,990 | 2026-01-07 | Filing | |
| $112.62 | 3,632 | $409,029.30 | 21,078 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,160,768 | $1,242,100,844 | 0.02% | |
| 2. | 11,317,714 | $1,155,991,262 | 0.02% | |
| 3. | 5,315,934 | $542,969,482 | 0.08% | |
| 4. | 4,890,026 | $499,467,256 | 0.42% | |
| 5. | 3,528,656 | $360,416,924 | 0.06% |
News See All
What Makes Guardant Health (GH) a Good Healthcare Holding
Carillon Tower Advisers, an investment management company, released its fourth-quarter 2025 investor letter for the “Carillon Eagle Small Cap Growth Fund”.
13 Best Russell 2000 Stocks to Buy Right Now
On January 6, Royce Investment Partners released their outlook for the small-cap stocks in 2026.
Strong Results and Improved Guidance Lifted Guardant Health (GH) in Q4
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Analysts Turn More Bullish on Guardant Health, Inc. (GH) as 2026 Growth Catalysts Build
TheFly reported on January 9 that Stifel increased its price target on GH to $120 from $100 while maintaining a Buy rating.
Top 10 Oncology Stocks to Buy Now
The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by 2034 with a compound annual growth rate of 11.75%.
Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH)
On January 5, 2026, TheFly reported that Wall Street firms had given Guardant Health, Inc. (NASDAQ:GH) two price target raises.
Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside
Guardant Health Inc. (NASDAQ:GH) is one of the hottest large-cap stocks of 2025.
10 Hottest Large-Cap Stocks of 2025
On December 22, Scott Wren, chief global equity strategist at Wells Fargo Investment Institute, joined CNBC's 'Squawk on the Street' to express optimism regarding accelerating earnings alongside moderating...
Hedge Fund Resource Center